Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9248d147fa3c26ff6a4e82ce0009203 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 |
filingDate |
2004-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d57c8bcdab9c155959b5a3becbe1f23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b4f28f0a7f776bdcf7050ba22217012 |
publicationDate |
2005-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1582213-A1 |
titleOfInvention |
Use of adenosine for treating surgery related ischemia |
abstract |
The present invention is related to the use of adenosine for the manufacture of a medicamentnfor the treatment of a human condition whereby the condition is selected from the groupncomprising surgery, ischemia, trauma, and hypoxia, characterised in that the adenosine isnadministered to the patient prior to the condition and after the condition. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008055875-A1 |
priorityDate |
2004-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |